RxTrials Institute Drug Pipeline Alert
May 21, 2008 | Vol. 6 No. 21
Generic Heart Drug Dosage Approved
KV Pharmaceutical has received final approval from the FDA of its ANDA to market its 50-mg strength of metoprolol succinate extended-release tablets.
This product is a generic version of AstraZeneca's Toprol-XL.
Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension used alone or in combination with other anti-hypertensive agents for the long-term treatment of angina pectoris, as well as for the treatment of stable, symptomatic heart failure, according to the company.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.